pre-IPO PHARMA

twentyeight-seven-therapeutics PRESS RELEASE ARCHIVE

Nov 2, 2022

Basilea announces sale of preclinical oncology program to Twentyeight-Seven Therapeutics


May 9, 2019

Sofinnova Partners Invests in Twentyeight-Seven Therapeutics


Sep 6, 2018

Twentyeight-Seven Therapeutics Launches with a $65 Million Series A Funding


Google Analytics Alternative